Pfizer to Buy a GLP-1 Drugmaker? Here’s Why You Shouldn’t Count on That Happening
The Motley FoolPfizer’s debt load could inhibit the company’s ability to take on acquisitions in the near term.
Pfizer’s debt load could inhibit the company’s ability to take on acquisitions in the near term.